Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

TriSalus Life Sciences (TLSIW) Inventory (2022 - 2025)

TriSalus Life Sciences' Inventory history spans 4 years, with the latest figure at $3.1 million for Q4 2025.

  • For Q4 2025, Inventory fell 23.99% year-over-year to $3.1 million; the TTM value through Dec 2025 reached $3.1 million, down 23.99%, while the annual FY2025 figure was $3.1 million, 23.99% down from the prior year.
  • Inventory reached $3.1 million in Q4 2025 per TLSIW's latest filing, down from $3.3 million in the prior quarter.
  • In the past five years, Inventory ranged from a high of $4.2 million in Q1 2025 to a low of $1.5 million in Q4 2022.
  • Average Inventory over 4 years is $3.1 million, with a median of $3.3 million recorded in 2025.
  • Peak YoY movement for Inventory: soared 145.49% in 2024, then fell 23.99% in 2025.
  • A 4-year view of Inventory shows it stood at $1.5 million in 2022, then skyrocketed by 73.01% to $2.5 million in 2023, then soared by 59.06% to $4.0 million in 2024, then dropped by 23.99% to $3.1 million in 2025.
  • Per Business Quant, the three most recent readings for TLSIW's Inventory are $3.1 million (Q4 2025), $3.3 million (Q3 2025), and $3.8 million (Q2 2025).